Foreign investment in Tel Aviv Stock Exchange tripled in 2013

Nonresident net investments reached about $1.5b in TASE shares in 2013, primarily in pharmaceuticals, banking and communications.

By
February 9, 2014 13:41
Tel Aviv Stock Exchange

Tel Aviv Stock Exchange TASE 311 (R). (photo credit: Gil Cohen Magen / Reuters)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Foreign investments in companies traded on the Tel Aviv Stock Exchange more than tripled from 2012 to 2013, according to figures the Bank of Israel released Sunday.

Nonresident net investments reached about $1.5 billion in TASE shares in 2013, primarily in pharmaceuticals, banking and communications industries. In 2012, the figure amounted to only $410 million, indicating an increase of some 266% in 2013.

Nonresidents also bought $940 million in Israeli shares that were traded abroad, on exchanges such as the NASDAQ, in 2013.


All in all, though, Israelis invested more of their money abroad, with Israel's institutional investors putting some $3.36 billion into foreign shares, households investing $2.1 billion, and the business sector investing $1.3 billion abroad.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS